Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v. - telaprevir - hepatitis c, kronični - antivirusi za sistemsko uporabo - incivo, v kombinaciji z peginterferon alfa in ribavirin, je primerna za zdravljenje genotip-1 kronični hepatitis c pri odraslih bolnikih z odškodnina za bolezni jeter (vključno s cirozo):kdo so zdravljenje naivna;, ki so že bili zdravljeni z interferonom alfa (pegylated ali ne-pegylated) sam ali v kombinaciji z ribavirin, vključno z relapsers, delno odzvali in nič na kraju nesreče.

Evropska unija - slovenščina - EMA (European Medicines Agency)

astrazeneca ab - fulvestrant - neoplazme dojke - endokrini terapije, anti-estrogene - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. v pre - ali perimenopausal ženske, kombinacija zdravljenja z palbociclib je treba v kombinaciji z luteinizirajoči hormon sproščujoči hormon (lhrh) agonist.

Evropska unija - slovenščina - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazme dojke - antineoplastična sredstva - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Evropska unija - slovenščina - EMA (European Medicines Agency)

pharmaand gmbh - rucaparib camsylate - ovarijske neoplazme - antineoplastična sredstva - rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. rubraca je označen kot monotherapy za vzdrževanje zdravljenje odraslih bolnikov s platino-občutljive relapsed visoko-kakovostni razred epitelnih jajčnikov, fallopian tube, ali primarni trebušno raka, ki so v odziv (popolna ali delna) platinum, ki temelji kemoterapijo.

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v.    - amivantamab - karcinom, pljučni pljuč - antineoplastična sredstva - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

hrvatski zavod za transfuzijsku medicinu - natrijev klorid - raztopina za infundiranje - natrijev klorid 9 mg / 1 ml - elektroliti

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

hrvatski zavod za transfuzijsku medicinu - natrijev klorid - raztopina za infundiranje - natrijev klorid 9 mg / 1 ml - elektroliti

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

hrvatski zavod za transfuzijsku medicinu - natrijev klorid - raztopina za infundiranje - natrijev klorid 9 mg / 1 ml - elektroliti

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

baxter d.o.o. - glukoza, brezvodna; kalcijev klorid dihidrat; magnezijev klorid heksahidrat; natrijev hidrogenkarbonat; natrijev klorid; natrijev laktat - raztopina za peritonealno dializo - glukoza, brezvodna 13,6 g / 1000 ml  kalcijev klorid dihidrat0,18 g / 1000 ml  magnezijev klorid heksahidrat0,05 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; kalcijev klorid dihidrat 0,18 g / 1000 ml  magnezijev klorid heksahidrat0,05 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; magnezijev klorid heksahidrat 0,05 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; natrijev hidrogenkarbonat 2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; natrijev klorid 5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; natrijev laktat 1,68 g / 1000 ml - hipertonične raztopine

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

baxter d.o.o. - glukoza, brezvodna; kalcijev klorid dihidrat; magnezijev klorid heksahidrat; natrijev hidrogenkarbonat; natrijev klorid; natrijev laktat - raztopina za peritonealno dializo - glukoza, brezvodna 22,7 g / 1000 ml  kalcijev klorid dihidrat0,18 g / 1000 ml  magnezijev klorid heksahidrat0,05 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; kalcijev klorid dihidrat 0,18 g / 1000 ml  magnezijev klorid heksahidrat0,05 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; magnezijev klorid heksahidrat 0,05 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; natrijev hidrogenkarbonat 2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; natrijev klorid 5,38 g / 1000 ml  natrijev laktat1,68 g / 1000 ml; natrijev laktat 1,68 g / 1000 ml - hipertonične raztopine